Delivery Order SPE2DB24D2101-SPE2DB25FKMLD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Atorvastatin 80 mg tablets in unit dose packaging of 30 units, with a ceiling value of $1,671.03. This is a firm fixed price delivery order with no set-aside designation, executed competitively. The order is scheduled for ultimate completion by May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 80 mg Atorvastatin tablets. The $2,088.50 firm-fixed-price contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities, including...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Atorvastatin 20 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,093.56. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-competitive, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a $1,584.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,651,931 units of Atorvastatin 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,409.36 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Atorvastatin 40 mg, a generic statin medication commonly used for cholesterol management. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. The order is for 4,564,097,707 units of Atorvastatin 10 mg tablets, a generic pharmaceutical product, with a ceiling value of $3,735.53. The delivery order has an ultimate completion date of March 28, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Atorvastatin 40 mg, a generic statin medication commonly used for cholesterol management in military and veteran healthcare systems. The order, valued at $1,465.15 with a firm fixed price structure, was competitively awarded without set-aside restrictions and is scheduled for completion by August 21, 2025. Performance will be executed at the contractor's facility in Conshohocken,...
- This federal contract award, valued at $1,628.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,405,913 units of Atorvastatin 80 mg tablets, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price, and has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a $12,618.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 15, 2024, for the supply of Atorvastatin Calcium, a widely-used statin medication for cholesterol management. The contract, which represents a child delivery order under a larger indefinite delivery vehicle, was competitively awarded with no set-aside designation. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,565,404,327 units of Atorvastatin 20 mg tablets. The contract, valued at $3,596.23, was awarded by the Defense Logistics Agency (DLA) on August 9, 2024, with a completion date of August 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMLDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,278.97 to AmerisourceBergen Drug Corp for the supply of Atorvastatin 80 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of July 17, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, with AmerisourceBergen Drug Corp positioned as a prime vendor for the DLA's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/16/25 |